PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21528155-0	2011	All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder.	Tretinoin	10-23	CD38 molecule	Homo sapiens	44-48	
21528155-5	2011	One of these, all-trans retinoic acid (ATRA), a known inducer of CD38, was added during cell culture and tested on a large sample of N = 120 lymphoblastoid cell (LBC) lines from ASD patients and their parents.	Tretinoin	14-37	CD38 molecule	Homo sapiens	65-69	
21528155-5	2011	One of these, all-trans retinoic acid (ATRA), a known inducer of CD38, was added during cell culture and tested on a large sample of N = 120 lymphoblastoid cell (LBC) lines from ASD patients and their parents.	Tretinoin	39-43	CD38 molecule	Homo sapiens	65-69	
21528155-6	2011	Analysis of CD38 mRNA levels shows that ATRA has an upmodulatory potential on LBC derived from ASD patients as well as from their parents.	Tretinoin	40-44	CD38 molecule	Homo sapiens	12-16	
21528155-9	2011	In addition, analysis of the role of genetic polymorphisms in the dynamics of the molecule revealed that the genotype of a single-nucleotide polymorphism (rs6449182; C>G variation) in the CpG island of intron 1, harboring the retinoic-acid response element, exerts differential roles in CD38 expression in ASD and in parental LBC.	Tretinoin	229-242	CD38 molecule	Homo sapiens	290-294